Molecular Orbital Studies of Antischistosomal Agents

Molecular orbital calculations were used to investigate the antischistosomal agent, niridazole, and an inactive derivative, 1‐(5‐nitro‐2‐thiazolyl)‐2‐ethylurea. The CNDO/2 calculations revealed that the inactive derivative had a preferred conformation stabilized by an intramolecular hydrogen bond. T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 1976-11, Vol.65 (11), p.1704-1705
Hauptverfasser: Aldrich, Haven S., Clagett, Donald C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1705
container_issue 11
container_start_page 1704
container_title Journal of pharmaceutical sciences
container_volume 65
creator Aldrich, Haven S.
Clagett, Donald C.
description Molecular orbital calculations were used to investigate the antischistosomal agent, niridazole, and an inactive derivative, 1‐(5‐nitro‐2‐thiazolyl)‐2‐ethylurea. The CNDO/2 calculations revealed that the inactive derivative had a preferred conformation stabilized by an intramolecular hydrogen bond. The molecular profile, the relative three‐dimensional arrangement of constituent atoms, of the inactive derivative was different than that of the niridazole compound. The likelihood of similar intramolecular interactions rendering niridazole derivatives inactive is discussed. The results of the calculations suggest select structural modifications that might increase the efficacy of niridazole derivatives.
doi_str_mv 10.1002/jps.2600651138
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_83608618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915390353</els_id><sourcerecordid>83608618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3818-724c89b72814fd64c3c48f3d6136ae44ca46b91e7f4f702c8c291313139cb2e3</originalsourceid><addsrcrecordid>eNqFkLlPwzAchS3EVQorE0MnthRfceyxIE6VQ4CExGIlzi9gyFHsBOh_j6tUIAaEPHh433uyP4R2CR4TjOnBy8yPqcBYxIQwuYIGJKY4Epgkq2gQABqxmKtNtOX9Cw4YjuMNtK4Ux1gNEL9sSjBdmbrRtctsm5aju7bLLfhRU4wmdWu9eba-bXxThWzyBHXrt9FakZYedpb3EN2fHN8fnUXT69Pzo8k0MkwSGSWUG6myhErCi1xwwwyXBcsFYSIFzk3KRaYIJAUvEkyNNFQRtjjKZBTYEO33szPXvHXgW12F10BZpjU0ndeSCSwFkQEc96BxjfcOCj1ztkrdXBOsF5J0kKR_JIXC3nK5yyrIv_HeSohVH3_YEub_jOmLm7tf01HfDdLg87ubulctEpbE-uHqVMfTQ34l6a1-DLzseQgi3y047Y2F2kBuHZhW54396xdfCQyTfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83608618</pqid></control><display><type>article</type><title>Molecular Orbital Studies of Antischistosomal Agents</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Aldrich, Haven S. ; Clagett, Donald C.</creator><creatorcontrib>Aldrich, Haven S. ; Clagett, Donald C.</creatorcontrib><description>Molecular orbital calculations were used to investigate the antischistosomal agent, niridazole, and an inactive derivative, 1‐(5‐nitro‐2‐thiazolyl)‐2‐ethylurea. The CNDO/2 calculations revealed that the inactive derivative had a preferred conformation stabilized by an intramolecular hydrogen bond. The molecular profile, the relative three‐dimensional arrangement of constituent atoms, of the inactive derivative was different than that of the niridazole compound. The likelihood of similar intramolecular interactions rendering niridazole derivatives inactive is discussed. The results of the calculations suggest select structural modifications that might increase the efficacy of niridazole derivatives.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600651138</identifier><identifier>PMID: 994009</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>Antischistosomal agents-niridazole ; Antischistosomal agents—niridazole, preferred molecular conformation, effect on biological activity ; Chemical Phenomena ; Chemistry ; effect on biological activity ; Molecular Conformation ; Molecular orbital calculations-preferred conformations of niridazole and derivative ; Niridazole - analogs &amp; derivatives ; Niridazole and derivative-preferred molecular conformations ; Niridazole and derivative—preferred molecular conformations, effect on biological activity ; preferred molecular conformation ; preferred molecular conformations ; Quantum Theory ; Schistosomicides ; Structure-Activity Relationship ; Structure-activity relationships-niridazole and derivative ; Structure‐activity relationships—niridazole and derivative, preferred molecular conformations, effect on biological activity</subject><ispartof>Journal of pharmaceutical sciences, 1976-11, Vol.65 (11), p.1704-1705</ispartof><rights>1976 Wiley‐Liss, Inc., A Wiley Company</rights><rights>Copyright © 1976 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600651138$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600651138$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/994009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aldrich, Haven S.</creatorcontrib><creatorcontrib>Clagett, Donald C.</creatorcontrib><title>Molecular Orbital Studies of Antischistosomal Agents</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Molecular orbital calculations were used to investigate the antischistosomal agent, niridazole, and an inactive derivative, 1‐(5‐nitro‐2‐thiazolyl)‐2‐ethylurea. The CNDO/2 calculations revealed that the inactive derivative had a preferred conformation stabilized by an intramolecular hydrogen bond. The molecular profile, the relative three‐dimensional arrangement of constituent atoms, of the inactive derivative was different than that of the niridazole compound. The likelihood of similar intramolecular interactions rendering niridazole derivatives inactive is discussed. The results of the calculations suggest select structural modifications that might increase the efficacy of niridazole derivatives.</description><subject>Antischistosomal agents-niridazole</subject><subject>Antischistosomal agents—niridazole, preferred molecular conformation, effect on biological activity</subject><subject>Chemical Phenomena</subject><subject>Chemistry</subject><subject>effect on biological activity</subject><subject>Molecular Conformation</subject><subject>Molecular orbital calculations-preferred conformations of niridazole and derivative</subject><subject>Niridazole - analogs &amp; derivatives</subject><subject>Niridazole and derivative-preferred molecular conformations</subject><subject>Niridazole and derivative—preferred molecular conformations, effect on biological activity</subject><subject>preferred molecular conformation</subject><subject>preferred molecular conformations</subject><subject>Quantum Theory</subject><subject>Schistosomicides</subject><subject>Structure-Activity Relationship</subject><subject>Structure-activity relationships-niridazole and derivative</subject><subject>Structure‐activity relationships—niridazole and derivative, preferred molecular conformations, effect on biological activity</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLlPwzAchS3EVQorE0MnthRfceyxIE6VQ4CExGIlzi9gyFHsBOh_j6tUIAaEPHh433uyP4R2CR4TjOnBy8yPqcBYxIQwuYIGJKY4Epgkq2gQABqxmKtNtOX9Cw4YjuMNtK4Ux1gNEL9sSjBdmbrRtctsm5aju7bLLfhRU4wmdWu9eba-bXxThWzyBHXrt9FakZYedpb3EN2fHN8fnUXT69Pzo8k0MkwSGSWUG6myhErCi1xwwwyXBcsFYSIFzk3KRaYIJAUvEkyNNFQRtjjKZBTYEO33szPXvHXgW12F10BZpjU0ndeSCSwFkQEc96BxjfcOCj1ztkrdXBOsF5J0kKR_JIXC3nK5yyrIv_HeSohVH3_YEub_jOmLm7tf01HfDdLg87ubulctEpbE-uHqVMfTQ34l6a1-DLzseQgi3y047Y2F2kBuHZhW54396xdfCQyTfA</recordid><startdate>197611</startdate><enddate>197611</enddate><creator>Aldrich, Haven S.</creator><creator>Clagett, Donald C.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197611</creationdate><title>Molecular Orbital Studies of Antischistosomal Agents</title><author>Aldrich, Haven S. ; Clagett, Donald C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3818-724c89b72814fd64c3c48f3d6136ae44ca46b91e7f4f702c8c291313139cb2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Antischistosomal agents-niridazole</topic><topic>Antischistosomal agents—niridazole, preferred molecular conformation, effect on biological activity</topic><topic>Chemical Phenomena</topic><topic>Chemistry</topic><topic>effect on biological activity</topic><topic>Molecular Conformation</topic><topic>Molecular orbital calculations-preferred conformations of niridazole and derivative</topic><topic>Niridazole - analogs &amp; derivatives</topic><topic>Niridazole and derivative-preferred molecular conformations</topic><topic>Niridazole and derivative—preferred molecular conformations, effect on biological activity</topic><topic>preferred molecular conformation</topic><topic>preferred molecular conformations</topic><topic>Quantum Theory</topic><topic>Schistosomicides</topic><topic>Structure-Activity Relationship</topic><topic>Structure-activity relationships-niridazole and derivative</topic><topic>Structure‐activity relationships—niridazole and derivative, preferred molecular conformations, effect on biological activity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aldrich, Haven S.</creatorcontrib><creatorcontrib>Clagett, Donald C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aldrich, Haven S.</au><au>Clagett, Donald C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular Orbital Studies of Antischistosomal Agents</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1976-11</date><risdate>1976</risdate><volume>65</volume><issue>11</issue><spage>1704</spage><epage>1705</epage><pages>1704-1705</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>Molecular orbital calculations were used to investigate the antischistosomal agent, niridazole, and an inactive derivative, 1‐(5‐nitro‐2‐thiazolyl)‐2‐ethylurea. The CNDO/2 calculations revealed that the inactive derivative had a preferred conformation stabilized by an intramolecular hydrogen bond. The molecular profile, the relative three‐dimensional arrangement of constituent atoms, of the inactive derivative was different than that of the niridazole compound. The likelihood of similar intramolecular interactions rendering niridazole derivatives inactive is discussed. The results of the calculations suggest select structural modifications that might increase the efficacy of niridazole derivatives.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><pmid>994009</pmid><doi>10.1002/jps.2600651138</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 1976-11, Vol.65 (11), p.1704-1705
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_83608618
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Antischistosomal agents-niridazole
Antischistosomal agents—niridazole, preferred molecular conformation, effect on biological activity
Chemical Phenomena
Chemistry
effect on biological activity
Molecular Conformation
Molecular orbital calculations-preferred conformations of niridazole and derivative
Niridazole - analogs & derivatives
Niridazole and derivative-preferred molecular conformations
Niridazole and derivative—preferred molecular conformations, effect on biological activity
preferred molecular conformation
preferred molecular conformations
Quantum Theory
Schistosomicides
Structure-Activity Relationship
Structure-activity relationships-niridazole and derivative
Structure‐activity relationships—niridazole and derivative, preferred molecular conformations, effect on biological activity
title Molecular Orbital Studies of Antischistosomal Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T09%3A52%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20Orbital%20Studies%20of%20Antischistosomal%20Agents&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Aldrich,%20Haven%20S.&rft.date=1976-11&rft.volume=65&rft.issue=11&rft.spage=1704&rft.epage=1705&rft.pages=1704-1705&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1002/jps.2600651138&rft_dat=%3Cproquest_cross%3E83608618%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83608618&rft_id=info:pmid/994009&rft_els_id=S0022354915390353&rfr_iscdi=true